These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38070617)

  • 1. Clinical and pharmacological implications for a high rate of unrecognized SARS-CoV-2 infected psychiatric patients.
    Vai B; Mazza MG
    Brain Behav Immun; 2024 Feb; 116():124-125. PubMed ID: 38070617
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk factors for recognized and unrecognized SARS-CoV-2 infection: a seroepidemiologic analysis of the Prospective Urban Rural Epidemiology (PURE) study.
    Leong DP; Loeb M; Mony PK; Rangarajan S; Mushtaha M; Miller MS; Dias M; Yegorov S; V M; Telci Caklili O; Temizhan A; Szuba A; Abat MEM; Mat-Nasir N; Diaz ML; Khansaheb H; Lopez-Jaramillo P; Duong M; Teo KK; Poirier P; Oliveira G; Avezum Á; Yusuf S
    Microbiol Spectr; 2024 Feb; 12(2):e0149223. PubMed ID: 38214526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 Seroprevalence and Clinical Features of COVID-19 in a German Liver Transplant Recipient Cohort: A Prospective Serosurvey Study.
    Rauber C; Tiwari-Heckler S; Pfeiffenberger J; Mehrabi A; Lund F; Gath P; Mieth M; Merle U; Rupp C
    Transplant Proc; 2021 May; 53(4):1112-1117. PubMed ID: 33451759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Characteristics of COVID-19 in Gynecological Cancer Patients during Chemotherapy-An Observational Study.
    Li Y; Sang C; Ru X; Wang S; Wang H
    Discov Med; 2024 Feb; 36(181):393-401. PubMed ID: 38409844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-hospital adverse outcomes and risk factors among chronic kidney disease patients infected with the omicron variant of SARS-CoV-2: a single-center retrospective study.
    Guo Y; Guo Y; Ying H; Yu W; Chen S; Zhang Y; Zhang S; Lin Y; Sun F; Zhang Y; Yu J; Ma K; Qin L; Long F; Zhu H; Mao R; Xue J; Zhang J
    BMC Infect Dis; 2023 Oct; 23(1):698. PubMed ID: 37853317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients.
    Taquet M; Sillett R; Zhu L; Mendel J; Camplisson I; Dercon Q; Harrison PJ
    Lancet Psychiatry; 2022 Oct; 9(10):815-827. PubMed ID: 35987197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Universal screening for SARS-CoV-2 infection: a rapid review.
    Viswanathan M; Kahwati L; Jahn B; Giger K; Dobrescu AI; Hill C; Klerings I; Meixner J; Persad E; Teufer B; Gartlehner G
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD013718. PubMed ID: 33502003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) exposure investigations using genomic sequencing among healthcare workers and patients in a large academic center.
    Smith L; Morris CP; Jibowu MH; Fallon S; Ray SC; Cosgrove SE; Curless MS; Fabre V; Karaba SM; Maragakis LL; Milstone AM; Sick-Samuels AC; Trexler P; Mostafa HH; Rock C;
    Infect Control Hosp Epidemiol; 2023 May; 44(5):798-801. PubMed ID: 35232508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 Infection and Risk of Postacute Psychiatric and Neurologic Diagnoses: A Nationwide Danish Cohort Study.
    Nielsen NM; Spiliopoulos L; Hansen JV; Videbech P; Hviid A
    Neurology; 2024 Mar; 102(5):e208113. PubMed ID: 38382013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune Response Is Key to Genetic Mechanisms of SARS-CoV-2 Infection With Psychiatric Disorders Based on Differential Gene Expression Pattern Analysis.
    Xia J; Chen S; Li Y; Li H; Gan M; Wu J; Prohaska CC; Bai Y; Gao L; Gu L; Zhang D
    Front Immunol; 2022; 13():798538. PubMed ID: 35185890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The differences in virus shedding time between the Delta variant and original SARS-CoV-2 infected patients.
    Li F; Deng J; Xie C; Wang G; Xu M; Wu C; Li J; Zhong Y
    Front Public Health; 2023; 11():1132643. PubMed ID: 37559731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxychloroquine efficacy and safety in preventing SARS-CoV-2 infection and COVID-19 disease severity during pregnancy (COVID-Preg): a structured summary of a study protocol for a randomised placebo controlled trial.
    González R; García-Otero L; Pons-Duran C; Marbán-Castro E; Goncé A; Llurba E; Gil MDM; Rodríguez-Zambrano MÁ; Chen H; Ramírez M; Bardají A; Menendez C
    Trials; 2020 Jul; 21(1):607. PubMed ID: 32616063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
    Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
    Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut Microbiota Status in COVID-19: An Unrecognized Player?
    Donati Zeppa S; Agostini D; Piccoli G; Stocchi V; Sestili P
    Front Cell Infect Microbiol; 2020; 10():576551. PubMed ID: 33324572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High rate of clinically unrecognized SARS-CoV-2 infections in pediatric palliative care patients.
    Bötticher B; Dinkelbach L; Hillebrecht M; Adams O; Dechert O; Trocan L; Neubert J; Borkhardt A; Janßen G
    Eur J Pediatr; 2022 Feb; 181(2):847-851. PubMed ID: 34467455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implications of COVID-19 in high burden countries for HIV/TB: A systematic review of evidence.
    Tamuzi JL; Ayele BT; Shumba CS; Adetokunboh OO; Uwimana-Nicol J; Haile ZT; Inugu J; Nyasulu PS
    BMC Infect Dis; 2020 Oct; 20(1):744. PubMed ID: 33036570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19-Associated Mortality in US Veterans with and without SARS-CoV-2 Infection.
    Suzuki A; Efird JT; Redding TS; Thompson AD; Press AM; Williams CD; Hostler CJ; Hunt CM
    Int J Environ Res Public Health; 2021 Aug; 18(16):. PubMed ID: 34444232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How concerned should we be about neurotropism of SARS-Cov-2? A brief clinical consideration of the possible psychiatric implications.
    De Berardis D
    CNS Spectr; 2022 Jun; 27(3):258-259. PubMed ID: 33300484
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of SARS-CoV-2 infections in healthcare workers with high and low exposures to Covid-19 patients in a Norwegian University Hospital.
    Handal N; Whitworth J; Blomfeldt A; Espvik HJ; Lysaker E; Berdal JE; Bakken Jørgensen S
    Infect Dis (Lond); 2021 Jun; 53(6):420-429. PubMed ID: 33620274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Socio-demographic and clinical characteristics of SARS-CoV-2-positive psychiatric in-patients: A case-control study in the psychiatric wards of a Great Metropolitan Hospital in Milan.
    Percudani M; Panariello A; Deste G; Bassetti R; Borriello G; Cecchetto F; Marco BD; Falini A; Nibbio G; Calzavara-Pinton I; Gulizia D; Lassini A; Lavatelli L; Levi D; Lise F; Malchiodi F; Mosca L; Piccinini G; Radice A; Romagnoni G; Ruzzi F; Turati S; Zanobio A; Vita A
    Psychiatry Res; 2023 Apr; 322():115042. PubMed ID: 36736155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.